2-(pyridin-3-yl)-ethyl methanesulfonate | 121688-28-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(pyridin-3-yl)-ethyl methanesulfonate
• 英文别名: 2-(Pyridin-3-yl)ethyl methanesulfonate；2-pyridin-3-ylethyl methanesulfonate
• CAS: 121688-28-6
• 化学式: C₈H₁₁NO₃S
• 分子量: 201.246
• InChiKey: YCCSZPAKMFCLRP-UHFFFAOYSA-N

物化性质

• 沸点：
  394.3±25.0 °C(Predicted)
• 密度：
  1.262±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  64.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(pyridin-3-yl)-ethyl methanesulfonate 在 potassium tert-butylate 作用下， 以 二甲基亚砜 为溶剂， 反应 1.0h， 生成 3-乙烯基吡啶
  参考文献：
  名称：

  Synthesis and pharmacological evaluation of some (pyridyl)cyclopropylmethyl amines and their methiodides as nicotinic receptor ligands

  摘要：

  A series of 3- and (4-pyridyl)cyclopropyimethyl amines and their quaternary ammonium derivatives have been synthesized; they can be considered as rigid analogues of nicotine. The compounds have been tested on rat cerebral cortex to measure the affinity for the central nicotinic receptor. Only the methiodides show affinity in the micromolar range. The results obtained can provide useful information on the topography of the nicotinic receptor-binding site. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

  DOI：

  10.1016/s0014-827x(02)01234-x
• 作为产物：
  描述：

  吡啶-3-乙酸盐酸盐 在 lithium aluminium tetrahydride 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 30.0h， 生成 2-(pyridin-3-yl)-ethyl methanesulfonate
  参考文献：
  名称：

  Synthesis and Biological Evaluation at Nicotinic Acetylcholine Receptors of N-Arylalkyl- and N-Aryl-7-Azabicyclo[2.2.1]heptanes

  摘要：

  A new series of N-arylalkyl-substituted 7-azabicyclo[2.2.1]heptanes and N-aryl-substituted 7-azabicyclo[2.2.1]heptanes were synthesized and evaluated as potential ligands for neuronal nicotinic acetylcholine receptors. The in vitro binding affinities (K-i) of the 7-azabicyclo[2.2.1]heptane derivatives were measured by inhibition of [H-3]cytisine binding to rat brain tissue. The most potent ligand of the series was found to be N-(3-pyridylmethyl)-7-azabicyclo[2.2.1]heptane (5b, K-i = 98 nM). The chloro analogue (5a, K-i = 245 nM) 5a and epibatidine (1) produced dose-dependent analgesia in both hotplate and tail-flick tests when administered subcutaneously. However, when compounds 1 and 5a,b were administered intrathecally, all produced analgesia in the tail-flick test but only 5a produced analgesia in the hotplate test.

  DOI：

  10.1021/jm0103561

文献信息

• Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB₂ Cannabinoid Receptor Activity
  作者：Jennifer M. Frost、Michael J. Dart、Karin R. Tietje、Tiffany R. Garrison、George K. Grayson、Anthony V. Daza、Odile F. El-Kouhen、Betty B. Yao、Gin C. Hsieh、Madhavi Pai、Chang Z. Zhu、Prasant Chandran、Michael D. Meyer

  DOI：10.1021/jm901214q

  日期：2010.1.14

  affinity CB2 agonists (5, 16). Substitution at the N1-indole position was then examined. A series of aminoalkylindoles was prepared and several substituted aminoethyl derivatives were active (23−27, 5) at the CB2 receptor. A study of N1 nonaromatic side chain variants provided potent agonists at the CB2 receptor (16, 35−41, 44−47, 49−54, and 57−58). Several polar side chains (alcohols, oxazolidinone) were

  已经制备了几种对CB 2大麻素受体具有高亲和力并且对CB 1受体具有选择性的3-酰基环吲哚。各种3-酰基取代基进行了调查，和四甲基环组被发现导致高亲和力CB 2激动剂（5，16）。然后检查在N1-吲哚位置的取代。（A系列aminoalkylindoles的制备和几个取代氨基乙基衍生物是活性23 - 27，5在CB）2受体。N1非芳香族侧链变异体的研究为CB 2受体提供了有效的激动剂（16，35 - 41，44 - 47，49 - 54，和57 - 58）。几个极性侧链（醇类，恶唑烷酮）的良好的耐受性为CB 2受体的活性（41，50），而其他（酰胺，酸）导致较弱的或无活性的化合物（55和56）。N1芳香族侧链还提供几个高亲和力CB 2受体激动剂（61，63，65，和69），但是在体外CB一般不太有效的2个功能测定法均高于非芳香族侧链类似物。
• NOVEL COMPOUNDS AS MODULATORS OF GLUCOCORTICOID RECEPTORS
  申请人：Thombare Pravin S.

  公开号：US20120220590A1

  公开（公告）日：2012-08-30

  Compounds of formula (I) and pharmaceutical compositions containing them are described. The use of the compounds and compositions are also described.

  描述了化合物(I)的结构和含有它们的药物组合物。还描述了这些化合物和组合物的用途。
• Peripheral vasodilating agent containing piperidine derivative as active
  申请人：Otsuka Pharmaceutical Co., Ltd.

  公开号：US05656642A1

  公开（公告）日：1997-08-12

  The present invention relates to novel peripheral vasodilating agents characterized by each containing as an active ingredient, a piperidine derivative or pharmaceutically acceptable salt thereof having excellent peripheral vasodilating activity. Said piperidine derivative or pharmaceutically acceptable salt thereof is represented by the general formula (1): ##STR1## (wherein R, R.sup.1 and R.sup.2 are the same as defined above.

  本发明涉及一种新型外周扩血管药物，其特征在于每种药物均包含作为活性成分的哌啶衍生物或其具有优异外周扩血管活性的药用盐。所述的哌啶衍生物或其药用盐由通式（1）表示：##STR1##（其中R、R.sup.1和R.sup.2与上文中定义的相同）。
• 四氢异喹啉类化合物
  申请人：江苏先声药业有限公司

  公开号：CN113493438A

  公开（公告）日：2021-10-12

  本发明提供了式(I)所示的取代芳基类化合物或药学可接受的盐，含有它们的药物组合物以及作为PRMT5抑制剂的用途。
• Methods of making 2,6-diaryl piperidine derivatives
  申请人：Chen Gang

  公开号：US20050154201A1

  公开（公告）日：2005-07-14

  Methods for preparing 2,6-diaryl piperidine derivatives are described. More particularly, 2,6-diaryl piperidines having formula 1-4 are prepared by cyclocondensation of an aryl or heteroaryl aldehyde with 1,3-acetonedicarboxylic acid.

  描述了制备2,6-二芳基哌啶衍生物的方法。更具体地，通过芳基或杂环芳基醛与1,3-乙二酸二甲酯进行环缩合反应制备具有1-4式的2,6-二芳基哌啶。